期刊文献+

人源抗Trop-2 Fab对宫颈癌细胞生物学特性的影响 被引量:4

Effects of human anti-Trop-2 Fab antibody on biological characteristics of cervical cancer cells
在线阅读 下载PDF
导出
摘要 目的 :观察人源抗Trop-2 Fab对宫颈癌细胞生物学特性的影响。方法 :流式细胞术和免疫荧光检测宫颈癌Hela细胞表面Trop-2蛋白的表达;划痕实验和Transwell检测人源抗Trop-2 Fab对宫颈癌细胞迁移能力的影响;流式细胞术检测人源抗Trop-2 Fab对宫颈癌细胞凋亡的诱导作用;CCK-8(cell counting kit-8)检测人源抗Trop-2 Fab对宫颈癌细胞增殖的影响。结果:Hela细胞表面有Trop-2蛋白表达,人源抗Trop-2 Fab能够抑制Hela细胞的增殖,有效降低Hela细胞的迁移和侵袭能力,同时能够诱导Hela细胞凋亡。结论:人源抗Trop-2 Fab能明显降低宫颈癌细胞的恶性生物学行为,Trop-2可作为宫颈癌治疗的潜在靶点。 Objective:To investigate effects of human anti-Trop-2 Fab antibody on biological characteristics of cervical cancer cells. Methods:The expression of Trop-2 protein from cervical cancer cells was assessed by flow cytometry(FCM)and immunofluorescence. The effect of human anti-Trop-2 Fab antibody on migration in human cervical cells was examined by wound healing assay and transwell test. Cell apoptosis induced by Trop-2 Fab was analyzed by flow cytometry. Human anti-Trop-2 Fab antibody influence on cervical cell proliferation was detected by cell counting kit-8(CCK8)assay. Results:Trop-2 protein was confirmed to express on human cervical cells. Human anti-Trop-2 Fab antibody inhibited human cervical cancer cell growth, migration and invasion, at the same time induced cervical cancer cell apoptosis. Conclusion:Human anti-Troo-2 Fab antibody can significantly inhibit the malignant biological behavior of cervical cancer cells. This fusion antibody may play a role in tumor targeting therapy, and Trop-2 may be a potential therapeutic target for cervical cancer.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2015年第3期320-325,共6页 Journal of Nanjing Medical University(Natural Sciences)
基金 南京市医学科技发展项目(ZKX12025) 南京市科学技术委员会第八批科技发展项目(201208025) 江苏省妇幼保健科研项目(F201211)
关键词 人源抗Trop2抗体 宫颈癌 生物学特性 human anti-Trop2 Fab antibody cervical cancer biological characteristics
作者简介 通信作者(Corresponding author),E—mail:thua8@163.com;zhujin1968@njmu.edu.cn
  • 相关文献

参考文献16

  • 1Ferlay J,Shin HR,Bray F,et al. Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J]. Int J Cancer,2010,127(12) :2893-2917.
  • 2Varughese J,Coceo E,Bellone S,et al. Cervical carcino- mas overexpress human trophoblast cell-surface marker (Trop-2)and are highly sensitive to immunotherapy with hRS7,a humanized monoclonal anti-Trop-2 antibody [J]. Am J Obstet Gynecol, 2011,205(6) : 5671-5677.
  • 3E1 Sewedy T, Fornaro M, Alberti S. Cloning of the murine TROP2 gene_conservation of a PIP2-binding sequence in the cytoplasmic domain of TROP-2[J]. Int J Cancer, 1998,75 (2) : 324-330.
  • 4Ohmaehi T,Tanaka F,Mimori K,et al. Clinical signifi- cance of TROP2 expression in colorectal cancer[J]. Clin Cancer Res, 2006, 12(10) : 3057-3063.
  • 5Fong D,Moser P,Krammel C,et al. High expression of TROP2 correlates with poor prognosis in pancreatic can-cer[J]. Br J Cancer,2008,99(8) : 1290-1295.
  • 6Fong D, Spizzo G, Gostner JM, et al. TROP2: a novel prog- nostic marker in squamous cell carcinoma of the oral cavity[J]. Mod Pathol, 2008,21(2) : 186-191.
  • 7Santin AD, Zhan F, Bellone S, et al. Gene expression pro- files in primary ovarian serous papillary tumors and nor- mal ovarian epithelium:identification of candidate molec- ular markers for ovarian cancer diagnosis and therapy[J]. Int J Cancer, 2004,112( 1 ) : 14-25.
  • 8Huang E,Cheng SH,Dressman H,et al. Gene expression predictors of breast cancer outcomes[J]. The Lancet, 2003,361 (9369):1590-1596.
  • 9Bignotti E,Todeschini P,Calza S,et al. Trop-2 overex- pression as an independent marker for poor overall sur- vival in ovarian carcinoma patients[J]. Eur J Cancer, 2010,46(5) :944-953.
  • 10Wang J, Day R, Dong Y, et al. Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers [ J ]. Mol Cancer Ther, 2008,7 (2) : 280-285.

二级参考文献34

  • 1Wan-Yee Lau,Eric C.H.Lai.Development and controversies of adjuvant therapy for pancreatic cancer[J].Hepatobiliary & Pancreatic Diseases International,2008,7(2):121-125. 被引量:5
  • 2Iacobuzio-Donahue C A, Maitra A, Shen-Ong G L, et al. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol, 2002, 160(4): 1239-1249.
  • 3Larbouret C, Robert B, Navarro-Teulon I, et al. In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas. Clin Cancer Res, 2007, 13(11): 3356-3362.
  • 4Gamez-Varela D, Zwick-Wallasch E, Kntgen H, et al. Monoclonal antibody blockade of the human Eagl potassium channel function exerts antitumor activity. Cancer Res, 2007, 67(15): 7343-7349.
  • 5Ripani E, Sacchetti A, Corda D, et ol. Human TROP-2 is a tumor- associated calcium signal transducer. Int J Cancer, 1998, 76:671-676.
  • 6Villablanca E J, Renucci A, Sapede D, et ol. Control of cell migration in the zebrafish lateral line: implication of the gene tumour-associated calcium signal transducer, tacstd. Dev Dyn, 2006, 235(3): 1578-1588.
  • 7Guerra E, Trerotola M, Arciprete R D, etal. A bicistronic cyclin D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. Cancer Res, 2008, 68(19): 8113-8121.
  • 8Alberti S, Vacca G, Trerotola M, et ol. Trop-2 is a novel PKC- dependent growth-stimulator trans-membrane molecule and a metastasis marker in human cancer. Proc Amer Assoc Cancer Res,2006,47:2483.
  • 9Alberti S, Trerotola M, Vacca G, et al. Novel role of TROP2 in breast cancer growth and metastatization. Journal of Clinical Oncology, ASCO Annual Meeting Proceedings Part I, 2007, 25(18S): 10510.
  • 10Fong D, Spizzo G, Gostner J M, et al. TROP2: A novel prognostic marker in squamous cell carcinoma of the oral cavity. Modem Pathology, 2008, 21(12): 186-191.

共引文献9

同被引文献28

  • 1冯倩倩,卢丹.TROP2在宫颈病变中的表达及临床研究[J].实用妇科内分泌电子杂志,2020,7(28):53-53. 被引量:2
  • 2丰有吉,沈铿.妇产科学[M].2版.北京:人民卫生出版社,2010:325.
  • 3Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013 [J]. CA Cancer J Clin,2013,63(1):11-30.
  • 4Dornh~fer N,Spong S,Bennewith K,et al. Connective tissue growth factor-specific monoclonal antibody therapy in- hibits pancreatic tumor growth and metastasis[J]. Cancer Res,2006,66(11) :5816-5827.
  • 5Sawada N,Ishiwata T,Naito Z,et al. Immunohistochemi- cal localization of endothelial cell markers in solitary fi- brous tumor[ J ]. Pathol Int, 2002,52 (12) : 769-776.
  • 6Trerotola M, Cantanelli P, Guerra E, et al. Upregulation of Trop-2 quantitatively stimulates human cancer growth [J ]. Oncogene, 2013,32(2) : 222-233.
  • 7Guerra E,Trerotola M, Dell' Arciprete R,et al. A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer[J]. Cancer Res, 2008,68(19) :8113-8121.
  • 8Nakashima K,Shimada H,Ochiai T,et al. Serological i- dentification of TROF2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma[J]. Int J Cancer, 2004,112(6) : 1029-1035.
  • 9Cubas R,Zhang S,Li M,et al. Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway[J]. Mol Cancer,2010,9(6) :253.
  • 10Villablanca EJ,Renucci A,Sapede D,et al. Control of cell migration in the zebrafish lateral line:implication of the gene "turnout-associated calcium signal transducer, "tac- std[J]. Dev Dyn,2006,235(6) : 1578-1588.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部